Invention Grant
- Patent Title: p-38 kinase inhibitors
- Patent Title (中): p-38激酶抑制剂
-
Application No.: US10898581Application Date: 2004-07-23
-
Publication No.: US07700622B2Publication Date: 2010-04-20
- Inventor: Hengyuan Lang , Jiong Lan , Yunfeng Fang
- Applicant: Hengyuan Lang , Jiong Lan , Yunfeng Fang
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Sophie Binet Cross
- Main IPC: A61K31/44
- IPC: A61K31/44 ; C07D211/00 ; A61K31/517 ; C07D239/88
Abstract:
Compounds and compositions for modulating the activity of p38 kinases are provided, including p38α and p38β kinase. Methods for treating, preventing or ameliorating one or more symptoms of a p38 kinase mediated disease or disorder are also provided.
Public/Granted literature
- US20050020590A1 P-38 kinase inhibitors Public/Granted day:2005-01-27
Information query
